Modified AKT Substrate II
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| A05-58C | 1 mg | 150,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Peptide Substrates
The Modified AKT Substrate II peptide sequence (modified-CKRPRAASFAE) is based on the N-terminus of GSK3.
| Category | Peptide |
| Supplier | SignalChem |
| Application | KA |
| Regulatory Status | RUO |
| Research Field | AKT/PKB Pathway, Angiogenesis, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, Inflammation, Invasion/Metastasis, Metabolic Disorder, Neurobiology, NfkB Pathway, WNT Signaling |
| Format | 1mg/ml of modified peptide solution was supplied. |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.signalchem.com |
| Shipping Details | -20°C |
| Material Safety Data Sheet | Download PDF |
